CJC-1295 No Dac 5MG Peptide - 99% Pure Peptide | PeptiUAE

CJC-1295 (without DAC) is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH). It consists of a 29-amino acid sequence (GHRH 1-29) modified to increase its resistance to enzymatic degradation.

Scientific Overview

In laboratory and in vitro research, CJC-1295 (no DAC) is studied for its chemical and structural properties:

• Molecular Composition: The sequence Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂ is characterized by modifications that prevent rapid proteolysis, which is a common limitation of the native GHRH hormone.

• Biochemical Investigations: Laboratory studies utilize this reagent to examine signal transduction pathways, protein synthesis regulation, and cellular metabolic responses in controlled, non-human experimental models.

• Pharmacokinetics: The "no DAC" (Drug Affinity Complex) version lacks the chemical modification that binds to serum albumin, resulting in a shorter half-life compared to the DAC-modified variant, making it useful for experimental protocols requiring acute, rather than sustained, exposure.

Technical Specifications

• Chemical Name: CJC-1295 (GHRH 1-29)

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

• Molecular Weight: Approximately 3,367.9 g/mol

• Form: Lyophilized (freeze-dried) powder.

• Solubility: Soluble in sterile water, PBS, or standard aqueous laboratory buffer systems.

• Storage: Maintain at -20°C in a desiccated, moisture-free environment. Avoid repeated freeze-thaw cycles once the material is reconstituted to maintain structural integrity.

• Analytical Verification: Identity is confirmed through HPLC and mass spectrometry.

Research Use Disclaimer

For laboratory research purposes only. This material is not for human or veterinary use, nor for any cosmetic, food, or therapeutic applications. It is not approved by any regulatory agency for clinical use.